Semaglutide

Concentration: Commonly 2 mg, 10 mg, or 20 mg vials (lyophilized powder)

Composition: Synthetic GLP-1 analog, modified for extended activity

Formulation: Lyophilized acetate buffered peptide

Half-Life: ~7 days (engineered for weekly research dosing)

Primary Actions: Appetite suppression, glucose regulation, metabolic research

Studied for sustained weight reduction in obesity research models.

Explored for glycemic control and insulin sensitivity improvements.

Compared with Tirzepatide and Retatrutide as part of incretin mimetic research.

Demonstrated synergy in appetite regulation and metabolic studies.

Reconstitute with bacteriostatic water (NuroCore standard).

Swirl gently until fully dissolved.

Handle under sterile laboratory conditions.

Unreconstituted: Store at –20 °C.

Reconstituted: Refrigerate at 2–8 °C.

Appearance: Clear, colorless solution; discard if cloudy or particulate.

Category: Metabolic & Weight Management Research (NuroCore)

Use Case: Research into GLP-1 pathways, obesity, and glycemic regulation

Compliance Note: Classified strictly as a research compound